Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB-231 partly through suppression of the Akt pathway

International Journal of Oncology

Volumn 45, Issue 4, 2014, Pages 1629-1637

  Jin, Hana ^a   Lee, Won Sup ^a   Eun, So Young ^a   Jung, Ji Hyun ^a   Park, Hyeon Soo ^b   Kim, Gonsup ^b   Choi, Yung Hyun ^c,d   Ryu, Chung Ho ^b   Jung, Jin Myung ^a   Hong, Soon Chan ^a   Shin, Sung Chul ^b   Kim, Hye Jung ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Dong Eui University   (South Korea)

^d Dong Eui University   (South Korea)

Author keywords

Akt pathway; Breast cancer; Invasion; Morin; N cadherin

Indexed keywords

BETA CATENIN; GELATINASE B; GLYCOGEN SYNTHASE KINASE 3BETA; MORIN; NERVE CELL ADHESION MOLECULE; PROTEIN KINASE B; ANTINEOPLASTIC AGENT; FLAVONOID; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; BREAST METASTASIS; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SIZE; CELL INVASION; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CELL VIABILITY; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; ENZYME REPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRACELLULAR SIGNALING; MORACEAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; TUMOR INVASION; TUMOR XENOGRAFT; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; BREAST TUMOR; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; MORACEAE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PLANT EXTRACTS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84907469716     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2535     Document Type: Article

References (45)

1. Hayes DF, Isaacs C and Stearns V: Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 6: 375-392, 2001.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
3. Korean Breast Cancer Society: Korean breast cancer data of 1996. J Korean Surg Soc 55: 621-635, 1998.
4. Keen JC and Davidson NE: The biology of breast carcinoma. Cancer 97: 825-833, 2003. (Pubitemid 36125819)
5. Anandappa SY, Sibson R, Platt-Higgins A, Winstanley JH, Rudland PS and Barraclough R: Variant estrogen receptor α mRNAs in human breast cancer specimens. Int J Cancer 88: 209-216, 2000.
6. Mostert B, Sleijfer S, Foekens JA and Gratama JW: Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treat Rev 35: 463-474, 2009.
7. Yugarani T, Tan BKH, The M and Das NP: Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets. Lipids 27: 181-186, 1992.
8. Wu TW, Zeng LH, Wu J and Fung KP: Morin: a wood pigment that protects three types of human cells in the cardiovascular system against oxyradical damage. Biochem Pharmacol 47: 1099-1103, 1994. (Pubitemid 24103845)
9. Kleijnen J and Knipschild P: Ginkgo biloba . Lancet 340: 1136-1139, 1992.
10. McGregor D: Diets, food components and human cancer. Biotherapy 11: 189-200, 1998.
11. Robak J and Gryglewski RJ: Flavonoids are scavengers of superoxide anion. Biochem Pharmacol 37: 83-88, 1998.
12. Husain SR, Cillard J and Cillard P: Hydroxyl radical scavenging activity of flavonoids. Phytochemistry 26: 2489-2492, 1987.
13. Stavric B: Role of chemopreventers in human diet. Clin Biochem 27: 319-332, 1994.
14. Chang LW, Juang LJ, Wang BS, Wang MY, Tai HM, Hung WJ, Chen YJ and Huang MH: Antioxidant and antityrosinase activity of mulberry (Morus alba L.) twigs and root bark. Food Chem Toxicol 49: 785-790, 2011.
15. Ramanathan L, Das NP and Li QT: Studies on lipid oxidation in fish phospholipid liposomes. Biol Trace Elem Res 40: 59-70, 1994. (Pubitemid 24060623)
16. Hanasaki Y, Ogawaa S and Fukui S: The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 16: 845-850, 1994. (Pubitemid 24193534)
17. Nakadate T, Yamamoto S, Aizu E and Kato R: Effects of flavonoids and antioxidants on 12-O-tetradecanoylphorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds. Gann 75: 214-222, 1984. (Pubitemid 14107229)
18. Baumann J, Bruchhausen FV and Wurm G: Flavonoids and related compounds as inhibitors of arachidonic acid peroxidation. Prostaglandins 20: 627-639, 1980. (Pubitemid 11176169)
19. Francis AR, Shetty TK and Bhattacharya RK: Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis 10: 1953-1955, 1989. (Pubitemid 19244876)
20. Huang MT, Wood AW, Newmark HL, Sayer JM, Yagi H, Jerina DM and Conney AH: Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids. Carcinogenesis 4: 1631-1637, 1983. (Pubitemid 14206929)
21. Denda A, Ura H, Tsujiuchi T, Tsutsumi M, Eimoto H, Takashima Y, Kitazawa S, Kinugasa T and Konishi Y: Possible involvement of arachidonic acid metabolism in phenobarbital promotion of hepatocarcinogenesis. Carcinogenesis 10: 1929-1935, 1989. (Pubitemid 19244872)
22. Jin H, Lee WS, Yun JW, Jung JH, Lee SM, Kim HJ, Choi YH, Kim GS, Jung JM, Ryu CH, Shin SC and Hong SC: Flavonoids from Citrus unshiu Marc. inhibit cancer cell adhesion to endothelial cells by selective inhibition of VCAM-1. Oncol Rep 30: 2336-2342, 2013.
23. Vihinen P and Kahari VM: Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99: 157-166, 2002. (Pubitemid 34309470)
24. Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34, 2006. (Pubitemid 43723979)
25. Radisky ES and Radisky DC: Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 15: 201-212, 2010.
26. Lelongt B, Trugnan G, Murphy G and Ronco PM: Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J Cell Biol 136: 1363-1373, 1997. (Pubitemid 27421921)
27. Sarén P, Welgus HG and Kovanen PT: TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 157: 4159-4165, 1996. (Pubitemid 126449330)
28. Przybylowska K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, Rykala J, Kolacinska A, Morawiec Z, Drzewoski J and Blasiak J: Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Res Treat 95: 65-72, 2006. (Pubitemid 43228082)
29. Steeg PS: Cancer: micromanagement of metastasis. Nature 449: 671-673, 2007.
30. Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904, 2006.
31. Eccles SA and Welch DR: Metastasis: recent discoveries and novel treatment strategies. Lancet 369: 1742-1757, 2007. (Pubitemid 46755391)
32. White ES, Strom SR, Wys NL and Arenberg DA: Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J Immunol 166: 7549-7555, 2001. (Pubitemid 32525635)
33. Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H and Matsushima K: Significance macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6: 3282-3289, 2000. (Pubitemid 30637758)
34. Naylor MS, Stamp GW, Davies BD and Balkwill FR: Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer 58: 50-56, 1994.
35. Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67, 2010.
36. Wu ZS, Wu Q, Yang JH, Wang HQ, Ding XD, Yang F and Xu XC: Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int J Cancer 122: 2050-2056, 2008. (Pubitemid 351441195)
37. Suyama K, Shapiro I, Guttman M and Hazan RB: A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2: 301-314, 2002. (Pubitemid 41043964)
38. Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, Shan W, Dong X, Williams TM, Lisanti MP, Knudsen K and Hazan RB: N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res 67: 3106-3116, 2007. (Pubitemid 46724847)
39. Nagi C, Guttman M, Jaffer S, Qiao R, Keren R, Triana A, Li M, Godbold J, Bleiweiss IJ and Hazan RB: N-cadherin expression in breast cancer: correlation with an aggressive histologic variant- -invasive micropapillary carcinoma. Breast Cancer Res Treat 94: 225-235, 2005. (Pubitemid 41677627)
40. Walsh MM and Bleiweiss IJ: Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol 32: 583-589, 2001. (Pubitemid 32601239)
41. Ho AT, Voura EB, Soloway PD, Watson KL and Khokha R: MMP inhibitors augment fibroblast adhesion through stabilization of focal adhesion contacts and up-regulation of cadherin function. J Biol Chem 276: 40215-40224, 2001.
42. Covington MD, Burghardt RC and Parrish AR: Ischemiainduced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am J Physiol Renal Physiol 290: F43-F51, 2006.
43. Pon YL, Auersperg N and Wong AS: Gonadotropins regulate N-cadherinmediated human ovarian surface epithelial cell survival at both posttranslational and transcriptional levels through a cyclic AMP/protein kinase A pathway. J Biol Chem 280: 15438-15448, 2005. (Pubitemid 40562902)
44. Yoon SO, Shin S, Lee HJ, Chun HK and Chung AS: Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression. Mol Cancer Ther 5: 2666-2675, 2006.
45. Chung TW, Lee YC and Kim CH: Hepatitis B viral HBx induces matrix metallo- proteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J 18: 1123-1125, 2004. (Pubitemid 39561544)